Methods, formulations, and compositions for the treatment of amyloidosis aredescribed, whereby a therapeutically effective amount of a compound havingthe formula (I) wherein Y is SOX or OSOX independentlychosen for each occurrence; X is cationic group independently chosen for eachoccurrence; n is 1, 2, 3 or 4; and m is 1 or 2, is applied.